Close Menu

marketing agreement

NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

NEW YORK (GenomeWeb News) – Predictive Biosciences will offer its molecular diagnostic bladder cancer tests to Arup Laboratories' national network of clients under a deal announced today.

NEW YORK (GenomeWeb News) – Eastern Biotech and Life Sciences, Dubai and BGI Health have partnered to make available to parts of the Middle East a non-invasive prenatal diagnostic test for detecting trisomy 21.

NEW YORK (GenomeWeb News) – Arup Laboratories has become the latest lab to sign a deal to offer Natera's Panorama non-invasive prenatal screening test.

NEW YORK (GenomeWeb News) – Pathwork Diagnostics today announced a deal to offer its Pathwork Tissue of Origin Test for cancer diagnosis in China.

NEW YORK (GenomeWeb News) – Genetic testing laboratory Pathway Genomics today announced a partnership with Practice Fusion to offer its services to Practice Fusion's network of more than 150,000 medical professionals.

NEW YORK (GenomeWeb News) – NextGxDx will begin offering PreventionGenetics' test catalog through the NextGxDx platform under an agreement announced today.

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has signed an agreement to offer a non-invasive prenatal test developed by Natera.

NEW YORK (GenomeWeb News) – Advion today said that it has inked a distribution agreement with Konik Group covering Spain, Portugal, and South America, excluding Brazil.

NEW YORK (GenomeWeb News) – Saladax Biomedical today said that it will offer its My5-FU assay as part of its MyCare service offering later this year after regaining marketing rights to the test from Myriad Genetics.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.